Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells 22,238 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 22,238 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $20.47, for a total value of $455,211.86. Following the transaction, the insider directly owned 169,805 shares of the company’s stock, valued at $3,475,908.35. This represents a 11.58% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Alignment Healthcare Price Performance

NASDAQ:ALHC opened at $20.63 on Wednesday. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The business’s 50-day moving average price is $20.85 and its 200 day moving average price is $17.96. Alignment Healthcare, Inc. has a 52-week low of $11.63 and a 52-week high of $23.87. The firm has a market cap of $4.13 billion, a P/E ratio of -171.92, a PEG ratio of 5.29 and a beta of 1.16.

Analysts Set New Price Targets

ALHC has been the subject of a number of research reports. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday. KeyCorp reissued an “overweight” rating and set a $28.00 price objective on shares of Alignment Healthcare in a research note on Thursday, January 22nd. UBS Group lifted their target price on Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, January 14th. JPMorgan Chase & Co. boosted their target price on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $23.32.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Teacher Retirement System of Texas increased its position in shares of Alignment Healthcare by 85.8% during the 3rd quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock worth $1,794,000 after purchasing an additional 47,472 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in Alignment Healthcare during the 3rd quarter valued at $3,499,000. Inspire Investing LLC bought a new position in Alignment Healthcare in the 3rd quarter valued at $1,129,000. Ameritas Investment Partners Inc. increased its stake in shares of Alignment Healthcare by 32.9% in the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock valued at $182,000 after buying an additional 3,225 shares in the last quarter. Finally, Schroder Investment Management Group raised its holdings in shares of Alignment Healthcare by 28.7% in the second quarter. Schroder Investment Management Group now owns 248,163 shares of the company’s stock valued at $3,437,000 after buying an additional 55,314 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.